Location: Home > Pharma China Web Edition
  • search
  • go
  • Feature Articles
  • 3/13/2026China Private Biotech Financing Slows in February but Larger Deals Sig...
  • 3/12/2026China's Labs Race for the Next First-in-Class Breakthrough
  • 3/10/2026China Challenges High-Priced Gene Therapies with Lower-Cost Alternativ...
  • 3/10/2026China Biotech Dealmaking Defies Seasonal Slowdown as February Licensin...
  • 3/10/2026US Weighs Policy Measures to Address China Biotech Competition
  • 3/9/2026China Biotech Financing Rebounds in Early 2026 as RNA Deals and Global...
  • 3/4/2026China Biotech Outlicensing Surges Past US$52 Billion in Early 2026
  • 3/2/20262026 Biotech Playbook: Hong Kong at the Centre of China's Globalisatio...
  • 2/26/2026China's Healthcare Reform Playbook: Boosting Births and Opening the Do...
  • 2/25/2026China Outpaces US and EU in Drug R&D with Faster Trials and Lower Cost...
  • 2/25/2026Global Pharma Giants Rush to License Chinese Weight-Loss Drugs, Eye Ob...
  • 2/25/2026The Patent Term Compensation and Protection Scope in the Compensated P...
  • 2/24/2026After 230% Deal Size Explosion, China Is No Longer the 'Bargain Baseme...
  • 2/20/2026China Biotech Kicks Off 2026 with $863 Million in January Raises
  • 2/16/2026Long-Acting Obesity Drugs Drive Record January Licensing Boom for Chin...
  • 2/16/2026China's Innovation in Translational Medicine: Rethinking Early-stage C...
  • 2/13/2026China Biotech Dealmaking and Financing Stay Strong in January 2026 Des...
  • 2/12/2026China NMPA Approves Nine New Drugs in January 2026, Expanding Beyond O...
  • 2/12/2026Today's China Crucible: What It Means for Pharma (PharmExec)
  • 2/10/2026China Overhauls Drug Administration Rules, Emphasizing Quality and Cli...
  • 2/10/2026China Biotech Lights Up. U.S. Stocks Prepare For A New Powerhouse (IBD...
  • 2/5/2026Global Pharma in 2025: China Remains a Key Market Amid Rising Competit...
  • 2/5/2026China Biotech Emerges as Global Deal Powerhouse, Analysts Cite Strong ...
  • 1/29/2026China's Innovation in Translational Medicine: Rethinking Early-stage C...
  • 1/27/2026China's Labs Pull Ahead as Global Drugmakers Invest in Biotech Pioneer...
  • 1/27/2026China's Early-Stage Drug Advantage Seen Persisting: Pitchbook
  • 1/23/2026China's Commercial Health Insurance Payouts for Innovative Drugs and D...
  • 1/21/2026China Emerges as Credible Challenger to US in AI Drug Discovery, but M...
  • 1/17/2026China Biopharma Innovation Takes Center Stage at 2026 FIC Summit in Sa...
  • 1/13/2026China Biopharma Sees Record Financing and Licensing Activity in 2025
  • Page:1/6 Total number of articles:175: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group